» Articles » PMID: 36147548

Translational and Clinical Significance of DAMPs, PAMPs, and PRRs in Trauma-induced Inflammation

Overview
Publisher Fortune Journals
Date 2022 Sep 23
PMID 36147548
Authors
Affiliations
Soon will be listed here.
Abstract

Increased morbidity and mortality after polytrauma due to multiple organ failure (MOF) is a major concern for clinicians. Systemic inflammatory response syndrome (SIRS) and sepsis are the major underlying causes. Damage-associated molecular proteins (DAMPs) released after polytrauma induce an inflammatory immune response to repair the tissue, however, persistent inflammation finally results in immunosuppression and MOF. During immunosuppression, additional exposure of the traumatized tissue to pattern-associated molecular patterns (PAMPs) further adds to the continuum of inflammatory cascade causing sepsis. These two hits worsen the condition of the patient and increase morbidity and mortality. Thus, it is critical to stratify the patient based on trauma severity and inflammatory biomarkers levels and design treatment accordingly for a better clinical outcome. Although some of the molecular mechanisms involved in SIRS and MOF after polytrauma have been reported, there is limited information on the critical factors related to the study of DAMPs and PAMPs, including the timing of sampling (time elapsed after trauma), source of sampling (blood, urine, saliva), proteomics and metabolomics, multiplex plasma assay, comparative interpretation of the results from various sources and diagnostic value, and interpretation on the translational and clinical significance. Additionally, there is limited literature on DAMPs like heat shock proteins, mitochondrial DNA, neutrophil extracellular traps, and their role in SIRS and MOF. Further, it is also important to distinguish between the biomarkers of SIRS and sepsis in a time-bound window to have a better clinical outcome. This critical review focuses on these aspects to provide comprehensive information and thought-provoking discussion to design future investigation and clinical trials.

Citing Articles

Computational Biology in the Discovery of Biomarkers in the Diagnosis, Treatment and Management of Cardiovascular Diseases.

Batta I, Patial R, Sobti R, Agrawal D Cardiol Cardiovasc Med. 2024; 8(5):405-414.

PMID: 39328401 PMC: 11426419.


Systemic immune response of burns from the acute to chronic phase.

Osuka A, Shigeno A, Matsuura H, Onishi S, Yoneda K Acute Med Surg. 2024; 11(1):e976.

PMID: 38894736 PMC: 11184575. DOI: 10.1002/ams2.976.


The contribution of the meningeal immune interface to neuroinflammation in traumatic brain injury.

Mokbel A, Burns M, Main B J Neuroinflammation. 2024; 21(1):135.

PMID: 38802931 PMC: 11131220. DOI: 10.1186/s12974-024-03122-7.


Using the Traditional Ex Vivo Whole Blood Model to Discriminate Bacteria by Their Inducible Host Responses.

Chick H, Rees M, Lewis M, Williams L, Bodger O, Harris L Biomedicines. 2024; 12(4).

PMID: 38672079 PMC: 11047930. DOI: 10.3390/biomedicines12040724.


Trauma-associated extracellular histones mediate inflammation via a MYD88-IRAK1-ERK signaling axis and induce lytic cell death in human adipocytes.

Roos J, Zinngrebe J, Huber-Lang M, Lupu L, Schmidt M, Strobel H Cell Death Dis. 2024; 15(4):285.

PMID: 38653969 PMC: 11039744. DOI: 10.1038/s41419-024-06676-9.


References
1.
Riley J, Tait S . Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020; 21(4):e49799. PMC: 7132203. DOI: 10.15252/embr.201949799. View

2.
Kong C, Song W, Fu T . Systemic inflammatory response syndrome is triggered by mitochondrial damage (Review). Mol Med Rep. 2022; 25(4). PMC: 8915392. DOI: 10.3892/mmr.2022.12663. View

3.
Matsumoto H, Matsumoto N, Ogura H, Shimazaki J, Yamakawa K, Yamamoto K . The clinical significance of circulating soluble RAGE in patients with severe sepsis. J Trauma Acute Care Surg. 2015; 78(6):1086-93. DOI: 10.1097/TA.0000000000000651. View

4.
Timmermans K, Kox M, Vaneker M, van den Berg M, John A, van Laarhoven A . Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med. 2016; 42(4):551-561. PMC: 5413532. DOI: 10.1007/s00134-015-4205-3. View

5.
Aswani A, Manson J, Itagaki K, Chiazza F, Collino M, Wupeng W . Scavenging Circulating Mitochondrial DNA as a Potential Therapeutic Option for Multiple Organ Dysfunction in Trauma Hemorrhage. Front Immunol. 2018; 9:891. PMC: 5951958. DOI: 10.3389/fimmu.2018.00891. View